Jamie Heath

Jamie Heath is Apollo Therapeutics’ chief financial officer. He has over 25 years of experience in corporate finance based in London and New York, specializing in working with global life science companies. Recently, he served as chief development officer at BTG Plc with responsibility for corporate strategy and business development. In this role, he oversaw a number of acquisitions, in-licensing deals and joint ventures, including the sale of the company to Boston Scientific for $4 billion. Jamie has led numerous M&A and capital raising transactions and held senior roles at Merrill Lynch, Centerview Partners and Deutsche Bank. He holds a master’s degree from Oxford University.